Share Twitter LinkedIn Facebook Email Monica Morrow, MD from Memorial Sloan Kettering Cancer Center speaks about the SABCS 2021 Presentation Is less (or more) axillary surgery needed in the genomic era?
2025 Breast Cancer Updates: Dr. Evanthia Roussos Torres on Biomarkers, Immunotherapy, and the Future of Treatment – MOASC Breast 6 Mins Read
FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer Breast 2 Mins Read